The correlation of the IGF-I, IGFBP-3, and ALS generation test to height velocity after 6 months of recombinant growth hormone therapy in girls with Turner syndrome

Growth Hormone and IGF Research

Volumn 16, Issue 4, 2006, Pages 240-246

  Collett Solberg, Paulo F ^a   Pessoa de Queiroz, Andréa N ^a   Cardoso, Monique Esteves ^a   Jusan, Rafaela Cattan ^a   Vaisman, Mario ^a   Guimarães, Marília M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Growth; Growth hormone; IGF I; IGF I generation test; Turner syndrome

Indexed keywords

BIOCHEMICAL MARKER; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADOLESCENT; ANTHROPOMETRY; ARTICLE; BIOCHEMISTRY; BODY HEIGHT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; FEMALE; GROWTH RATE; HUMAN; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; SHORT STATURE; TREATMENT DURATION; TREATMENT OUTCOME; TURNER SYNDROME;

ADOLESCENT; AGE DETERMINATION BY SKELETON; AGE FACTORS; BODY HEIGHT; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; FEMALE; FORECASTING; GLYCOPROTEINS; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LONGITUDINAL STUDIES; STATISTICS; TIME FACTORS; TURNER SYNDROME;

EID: 33748031717     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2006.06.002     Document Type: Article

References (20)

1. Saenger P., Albertsson-Wikland K., Conway G.S., et al. Recommendations for the diagnosis and management of Turner syndrome. J. Clin. Endocrinol. Metab. 86 (2001) 3061-3069
2. Gravholt C.H. Epidemiological, endocrine and metabolic features in Turner syndrome. Eur. J. Endocrinol. 151 (2004) 657-687
3. Guimarães M.M., Guerra C.T.G., Alves S.T.F., et al. Intercorrências clínicas na síndrome de Turner. Arq. Bras. Endocrinol. Metab. 45/4 (2001) 331-338
4. Plotnick L., Attie K.M., Blethen S.L., and Sy J.P. Growth hormone treatment of girls with Turner syndrome: the national cooperative growth study experience. Pediatrics 102 (1998) 479-481
5. Rosenfeld R.G., Attie K.M., Frane J., et al. Growth hormone therapy of Turner's syndrome: beneficial effect on adult height. J. Pediatr. 132 (1998) 319-324
6. Ranke M.B., Lindberg A., Chatelain P., Wilton P., Cutfield W., Albertsson-Wikland K., and Price D.A. Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. J. Clin. Endocrinol. Metab. 85 (2000) 4212-4218
7. Collett-Solberg P.F., and Cohen P. Genetics, chemistry and function of the IGF/IGFBP system. Endocrine 12 (2000) 121-136
8. Kelley K.M., Oh Y., Gargosky S.E., Gucev Z., Matsumoto T., Hwa V., Ng L., Simpson D.M., and Rosenfeld R.G. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int. J. Biochem. Cell Biol. 28 (1996) 619-637
9. Juul A., Moller S., Mosfeldt-Laursen E., et al. The acid-labile subunit of human ternary insulin-like growth factor binding protein complex in serum: hepatosplanchnic release, diurnal variation, circulating concentrations in healthy subjects, and diagnostic use in patients with growth hormone deficiency. J. Clin. Endocrinol. Metab. 83 (1998) 4408-4415
10. Rosenfeld R.G., Albertsson-Wikland K., and Cassorla F. Diagnositc controversy: the diagnosis of childhood growth hormone deficiency revisited. J. Clin. Endocrinol. Metab. 80 (1995) 1532-1540
11. Sizonenko P.C., Clayton P.E., Cohen P., Hintz R.L., Tanaka T., and Laron Z. Diagnosis and management of growth hormone deficiency in childhood and adolescence. Part 1: diagnosis of growth hormone deficiency. Growth Horm. IGF Res. 11 (2001) 137-165
12. Thalange N.K.S., Price D.A., Gill M.S., Whatmore A.J., Addison G.M., and Clayton P.E. Insulin-like growth factor binding protein-3 Generation: An index of growth hormone insensitivity. Pediatr. Res. 39 (1996) 849-855
13. Schwarze C.P., Wollmann H.A., Binder G., and Ranke M.B. Short-term increments of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 predict the growth response to growth hormone (GH) therapy in GH-sensitive children. Acta Paediatr. Suppl. 428 (1999) 200-208
14. Buckway C.K., Guevara-Aguirre J., Pratt K.L., Burren C.P., and Rosenfeld R.G. The IGF-I generation test revisited: a marker of GH sensitivity. J. Clin. Endocrinol. Metab. 86 (2001) 5176-5183
15. Blum W.F., Cotterill A.M., Postel-Vinay M.C., Ranke M.B., Savage M.O., and Wilton P. Improvement of diagnostic criteria in growth hormone insensitivity syndrome: solutions and pitfalls. Pharmacia study group on insulin-like growth factor I treatment in growth hormone insensitivity syndromes. Acta Paediatr. Suppl. 399 (1994) 117-124
16. Gravholt C.H., Naeraa R.W., Brixem K., Kastrup K.W., Mosekilde L., Jorgensen J.O.E., and Chritiansen J.S. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study. Pediatrics 110 (2002) 889-896
17. Cuttler L., Vliet G.V., Conte F.A., Kaplan S.L., and Grumbach M.M. Somatomedin-C levels in children and adolescents with gonadal dysgenesis: differences from age-matched normal females and effect of chronic estrogen replacement therapy. J. Clin. Endocrinol. Metab. 60 (1985) 1087-1092
18. Haeusler G., Frisch H., Schmitt K., Blumel P., Plochl E., Zachmann M., and Waldhor T. Treatment of patients with Ullrich-Turner syndrome with conventional doses of growth hormone and the combination with testosterone or oxandrolone: effect on growth, IGF-I and IGFBP-3 concentrations. Eur. J. Pediatr. 154 (1995) 427-444
19. Dos Santos C., Essioux L., Teinturier C., Tauber M., Goffin V., and Bougnères P. A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat. Genet. 36 (2004) 720-724
20. Binder G., Baur F., Schweizer R., and Ranke M.B. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children. J. Clin. Endocrinol. Metab. 91 (2006) 659-664